FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/035095 [Registered on: 23/07/2021] Trial Registered Prospectively
Last Modified On: 21/07/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A comparative study about chemical peel in acne 
Scientific Title of Study   A RANDOMIZED control trial to compare the efficacy and safety of 40% mandelic acid peel with 30% salicylic acid peel in Acne vulgaris  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SHEA SHARMA B  
Designation  JUNIOR RESIDENT/ POST GRADUATE  
Affiliation  CHETTINAD ACADEMY OF RESEARCH AND EDUCATION  
Address  Room number 8, department of dermatology , A block ,Chettinad academy of research and institute, Rajiv Gandhi Salai , Kelambakkam, Chengalpattu

Kancheepuram
TAMIL NADU
603103
India 
Phone  7338932929  
Fax    
Email  sheabsharma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  G SRINIVASAN  
Designation  PROFESSOR 
Affiliation  CHETTINAD ACADEMY OF RESEARCH AND EDUCATION  
Address  Room no 8 , Department of dermatology , A block ,Chettinad academy of research and institute, Rajiv Gandhi Salai , Kelambakkam, Chengalpattu

Kancheepuram
TAMIL NADU
603103
India 
Phone  9443837085  
Fax    
Email  sriniraj07@gmail.com  
 
Details of Contact Person
Public Query
 
Name  SHEA SHARMA B  
Designation  JUNIOR RESIDENT/ POST GRADUATE  
Affiliation  CHETTINAD ACADEMY OF RESEARCH AND EDUCATION  
Address  Room no 8, department of dermatology, A block,Chettinad academy of research and institute, Rajiv Gandhi Salai , Kelambakkam, Chengalpattu

Kancheepuram
TAMIL NADU
603103
India 
Phone  7338932929  
Fax    
Email  sheabsharma@gmail.com  
 
Source of Monetary or Material Support  
CHETTINAD ACADEMY OF RESEARCH AND EDUCATION  
SHEA SHARMA B 
 
Primary Sponsor  
Name  SHEA SHARMA B 
Address  Chettinad academy of research and education, Rajiv Gandhi salai , OMR,Kelambakkam , Chennai -603103 
Type of Sponsor  Other [self ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SHEA SHARMA B  CHETTINAD HOSPITAL AND RESEARCH INSTITUTE  Room number 8 , department of dermatology, A block ,Chettinad health city, rajiv gandhi salai,kelambakkam
Kancheepuram
TAMIL NADU 
7338932929

sheabsharma@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL HUMAN ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  ACNE VULGARIS 
Patients  (1) ICD-10 Condition: L700||Acne vulgaris,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  MANDELIC ACID  40% MANDELIC ACID PEEL IS APPLIED TOPICALLY AND WASHED OFF AFTER 2 Mins AT EVERY 2 WEEK INTERVAL FOR 4 to 5 sittings 
Comparator Agent  SALICYLIC ACID  30% SALICYLIC ACID PEEL IS APPLIED TOPICALLY AND WASHED OFF AFTER FROSTING IS SEEN FOR EVERY 2 WEEK ONCE FOR 4 to 5 Sittings 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  PATIENTS OLDER THAN 18 YEARS OF AGE
PATIENT CONSENT FOR STUDY AND FOLLOW UP
PATIENT WILLING FOR CHEMICAL PEEL 
 
ExclusionCriteria 
Details  AGE LESS THAN 18 YEARS
PATIENTS NOT WILLING FOR STUDY AND CHEMICAL PEELING PROCEDURE
PATIENTS WHO ARE PREGNANT OR BREASTFEEDING
PATIENTS WITH HYPERSENSITIVITY TO FORMUKATIONS USED
PATIENTS ON ORAL ISOTRETINOIN
PATIENTS WITH IRREGULAR MENSTRUAL CYCLE
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
REDUCTION IN NUMBER OF OLD ACNE LESIONS   Baseline,4 weeks and10 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
REDUCTION IN NEW ACNE LESIONS  4 and 8 weeks 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   28/07/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   ACNE IS VERY COMMON PROBLEM ENCOUNTERED IN DERMATOLOGY OPD AND IT IS COSMETICALLY DISFIGURING. THOUGH CHEMICAL PEEL IS COMMON TREATMENT OPTION FOR ACNE VULGARIS , 40% MANDELIC ACID BEING A NEWLY EMERGING PEEL HAS NOT BEEN STUDIED MUCH .  
Close